Iva Miljkovic1, Joseph M Zmuda. 1. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. miljkovici@edc.pitt.edu
Abstract
PURPOSE OF REVIEW: To summarize the epidemiology of myosteatosis and its association with diabetes. RECENT FINDINGS: The role of myosteatosis (fat infiltration in skeletal muscle) in diabetes has received considerable attention. There is reasonably consistent evidence that myosteatosis contributes to glucose and insulin abnormalities and diabetes, possibly even independent of overall obesity. Novel hypotheses that link myosteatosis with insulin resistance and type 2 diabetes have also recently been proposed. These hypotheses suggest that impaired secretion of adipokines, modulation of nutritive blood flow to skeletal muscle, or both may be of importance for the development of myosteatosis. Recent longitudinal data also suggest that myosteatosis increases with aging, regardless of changes in body weight. SUMMARY: Further studies are needed to identify the specific physiological mechanisms that influence myosteatosis, and the mechanisms that link this fat depot with insulin resistance. Longitudinal studies are also needed to evaluate the remodeling of skeletal muscle fat with aging, across a wider age spectrum, and across different populations, especially those at high risk of developing diabetes. There is also a need to evaluate whether myosteatosis influences the incidence of type 2 diabetes independent of overall adiposity. A better understanding of the factors that regulate myosteatosis may lead to the development of novel therapies that influence a more metabolically 'healthy' skeletal muscle.
PURPOSE OF REVIEW: To summarize the epidemiology of myosteatosis and its association with diabetes. RECENT FINDINGS: The role of myosteatosis (fat infiltration in skeletal muscle) in diabetes has received considerable attention. There is reasonably consistent evidence that myosteatosis contributes to glucose and insulin abnormalities and diabetes, possibly even independent of overall obesity. Novel hypotheses that link myosteatosis with insulin resistance and type 2 diabetes have also recently been proposed. These hypotheses suggest that impaired secretion of adipokines, modulation of nutritive blood flow to skeletal muscle, or both may be of importance for the development of myosteatosis. Recent longitudinal data also suggest that myosteatosis increases with aging, regardless of changes in body weight. SUMMARY: Further studies are needed to identify the specific physiological mechanisms that influence myosteatosis, and the mechanisms that link this fat depot with insulin resistance. Longitudinal studies are also needed to evaluate the remodeling of skeletal muscle fat with aging, across a wider age spectrum, and across different populations, especially those at high risk of developing diabetes. There is also a need to evaluate whether myosteatosis influences the incidence of type 2 diabetes independent of overall adiposity. A better understanding of the factors that regulate myosteatosis may lead to the development of novel therapies that influence a more metabolically 'healthy' skeletal muscle.
Authors: Iva Miljkovic; Jane A Cauley; Moira A Petit; Kristine E Ensrud; Elsa Strotmeyer; Yahtyng Sheu; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Lewis H Kuller; Kimberly A Faulkner; Joseph M Zmuda Journal: J Clin Endocrinol Metab Date: 2009-05-19 Impact factor: 5.958
Authors: Seng Khee Gan; Katherine Samaras; Campbell H Thompson; Edward W Kraegen; Andrew Carr; David A Cooper; Donald J Chisholm Journal: Diabetes Date: 2002-11 Impact factor: 9.461
Authors: Karin E Shortreed; Matthew P Krause; Julianna H Huang; Dili Dhanani; Jasmin Moradi; Rolando B Ceddia; Thomas J Hawke Journal: PLoS One Date: 2009-10-06 Impact factor: 3.240
Authors: Tom E Nightingale; Pamela Moore; Joshua Harman; Refka Khalil; Ranjodh S Gill; Teodoro Castillo; Robert A Adler; Ashraf S Gorgey Journal: J Spinal Cord Med Date: 2017-08-03 Impact factor: 1.985
Authors: Britta Larsen; John Bellettiere; Matthew Allison; Robyn L McClelland; Iva Miljkovic; Chantal A Vella; Pamela Ouyang; Kimberly R De-Guzman; Michael Criqui; Jonathan Unkart Journal: Metabolism Date: 2020-07-23 Impact factor: 8.694
Authors: Iva Miljkovic; Allison L Kuipers; Jane A Cauley; Tanushree Prasad; Christine G Lee; Kristine E Ensrud; Peggy M Cawthon; Andrew R Hoffman; Thuy-Tien Dam; Christopher L Gordon; Joseph M Zmuda Journal: J Gerontol A Biol Sci Med Sci Date: 2015-04-02 Impact factor: 6.053
Authors: Qian Zhao; Joseph M Zmuda; Allison L Kuipers; Clareann H Bunker; Alan L Patrick; Ada O Youk; Iva Miljkovic Journal: Hypertension Date: 2017-03-06 Impact factor: 10.190
Authors: A W Frank; J P Farthing; P D Chilibeck; C M Arnold; W P Olszynski; S A Kontulainen Journal: J Nutr Health Aging Date: 2015-01 Impact factor: 4.075
Authors: Rachel E Ward; Paolo Caserotti; Jane A Cauley; Robert M Boudreau; Bret H Goodpaster; Aaron I Vinik; Anne B Newman; Elsa S Strotmeyer Journal: Aging Dis Date: 2015-11-27 Impact factor: 6.745